(Q33782683)

English

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (English)

1 reference

Europe PubMed Central

29 July 2017

0 references

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C Baigent

1

1 reference

Europe PubMed Central

29 July 2017

R Collins

2

1 reference

Europe PubMed Central

29 July 2017

P Appleby

3

1 reference

Europe PubMed Central

29 July 2017

S Parish

4

1 reference

Europe PubMed Central

29 July 2017

P Sleight

5

1 reference

Europe PubMed Central

29 July 2017

R Peto

6

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

29 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

29 July 2017

316

1 reference

Europe PubMed Central

29 July 2017

1337-1343

1 reference

Europe PubMed Central

29 July 2017

7141

1 reference

Europe PubMed Central

29 July 2017

Magnitude of benefit from earlier thrombolytic treatment in acute myocardial infarction: new evidence from Grampian region early anistreplase trial (GREAT)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis. Results of the GISSI-2 data base. The Ad hoc Working Group of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-2 Data Ba

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Gruppo Italiano per lo Studio della Streptochi-nasi nell'Infarto Miocardico (GISSI)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Long-term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of The Netherlands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Coronary thrombolysis for the elderly?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Anglo-Scandinavian Study of Early Thrombolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Allocation of patients to treatment groups in a controlled clinical study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

4 July 2018

Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

30 October 2018

Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction. Urochinasi per via Sistemica nell'Infarto Miocardico (USIM) Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28530

30 October 2018

A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct S

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombolysis for acute myocardial infarction. Why is there no extra benefit after hospital discharge?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Translation of clinical trials into practice: a European population-based study of the use of thrombolysis for acute myocardial infarction. European Secondary Prevention Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombolytic therapy for patients with myocardial infarction presenting after six hours

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term survival in 618 patients from the Western Washington streptokinase in myocardial infarction trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/9563981

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.316.7141.1337

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33782683&oldid=1901560063"